China prepares for coronavirus vaccine mass production though clinical trials are not yet complete | South China Morning Post

Several coronavirus vaccine developers in China have readied their facilities for mass production, even though the medicine is still undergoing clinical trials and has no market approval yet. Once found and approved, the Covid-19 vaccines will be in high demand for use in efforts to control the worldwide coronavirus…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.